Cargando…
Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension
OBJECTIVE: To study the effect of botulinum neurotoxin (BoNT) treatment in jerky and tremulous functional movement disorders (FMD). METHODS: Patients with invalidating, chronic (>1 year) symptoms were randomly assigned to two subsequent treatments with BoNT or placebo every 3 months with stratifi...
Autores principales: | Dreissen, Yasmine Emma Maria, Dijk, Joke M, Gelauff, Jeannette M, Zoons, Evelien, van Poppelen, Daniël, Contarino, Maria Fiorella, Zutt, Rodi, Post, Bart, Munts, Alexander G, Speelman, Johannes D, Cath, Danielle C, de Haan, Rob J, Koelman, Johannes HTM, Tijssen, Marina A J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860905/ https://www.ncbi.nlm.nih.gov/pubmed/31221722 http://dx.doi.org/10.1136/jnnp-2018-320071 |
Ejemplares similares
-
Myoclonus and other jerky movement disorders
por: van der Veen, Sterre, et al.
Publicado: (2022) -
Botulinum neurotoxin (BoNT) treatment in functional movement disorders: long-term follow-up
por: Dreissen, Yasmine EM, et al.
Publicado: (2020) -
Distribution and Coexistence of Myoclonus and Dystonia as Clinical Predictors of SGCE Mutation Status: A Pilot Study
por: Zutt, Rodi, et al.
Publicado: (2016) -
Jerky Periods: Myoclonus Occurring Solely During Menses
por: Buijink, Arthur W. G., et al.
Publicado: (2013) -
Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms
por: Zoons, E., et al.
Publicado: (2017)